311 related articles for article (PubMed ID: 21788281)
1. Growth factors and myometrium: biological effects in uterine fibroid and possible clinical implications.
Ciarmela P; Islam MS; Reis FM; Gray PC; Bloise E; Petraglia F; Vale W; Castellucci M
Hum Reprod Update; 2011; 17(6):772-90. PubMed ID: 21788281
[TBL] [Abstract][Full Text] [Related]
2. Expression of insulin-like growth factors (IGFs) and IGF signaling: molecular complexity in uterine leiomyomas.
Peng L; Wen Y; Han Y; Wei A; Shi G; Mizuguchi M; Lee P; Hernando E; Mittal K; Wei JJ
Fertil Steril; 2009 Jun; 91(6):2664-75. PubMed ID: 18439583
[TBL] [Abstract][Full Text] [Related]
3. The etiopathogenesis of uterine fibromatosis.
Manta L; Suciu N; Toader O; Purcărea RM; Constantin A; Popa F
J Med Life; 2016; 9(1):39-45. PubMed ID: 27974911
[TBL] [Abstract][Full Text] [Related]
4. Role of Transforming Growth Factor β in Uterine Fibroid Biology.
Ciebiera M; Włodarczyk M; Wrzosek M; Męczekalski B; Nowicka G; Łukaszuk K; Ciebiera M; Słabuszewska-Jóźwiak A; Jakiel G
Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29149020
[TBL] [Abstract][Full Text] [Related]
5. Signaling Pathways in Leiomyoma: Understanding Pathobiology and Implications for Therapy.
Borahay MA; Al-Hendy A; Kilic GS; Boehning D
Mol Med; 2015 Apr; 21(1):242-56. PubMed ID: 25879625
[TBL] [Abstract][Full Text] [Related]
6. Uterine fibroids.
Stewart EA; Laughlin-Tommaso SK; Catherino WH; Lalitkumar S; Gupta D; Vollenhoven B
Nat Rev Dis Primers; 2016 Jun; 2():16043. PubMed ID: 27335259
[TBL] [Abstract][Full Text] [Related]
7. Extracellular matrix in uterine leiomyoma pathogenesis: a potential target for future therapeutics.
Islam MS; Ciavattini A; Petraglia F; Castellucci M; Ciarmela P
Hum Reprod Update; 2018 Jan; 24(1):59-85. PubMed ID: 29186429
[TBL] [Abstract][Full Text] [Related]
8. Epigenetic and genetic landscape of uterine leiomyomas: a current view over a common gynecological disease.
Laganà AS; Vergara D; Favilli A; La Rosa VL; Tinelli A; Gerli S; Noventa M; Vitagliano A; Triolo O; Rapisarda AMC; Vitale SG
Arch Gynecol Obstet; 2017 Nov; 296(5):855-867. PubMed ID: 28875276
[TBL] [Abstract][Full Text] [Related]
9. The management of uterine leiomyomas.
Vilos GA; Allaire C; Laberge PY; Leyland N;
J Obstet Gynaecol Can; 2015 Feb; 37(2):157-178. PubMed ID: 25767949
[TBL] [Abstract][Full Text] [Related]
10. Uterine fibroids.
Bulun SE
N Engl J Med; 2013 Oct; 369(14):1344-55. PubMed ID: 24088094
[No Abstract] [Full Text] [Related]
11. Epigallocatechin Gallate for the Treatment of Benign and Malignant Gynecological Diseases-Focus on Epigenetic Mechanisms.
Włodarczyk M; Ciebiera M; Nowicka G; Łoziński T; Ali M; Al-Hendy A
Nutrients; 2024 Feb; 16(4):. PubMed ID: 38398883
[TBL] [Abstract][Full Text] [Related]
12. Determinants of serum cytokines in a population sample of healthy subjects from Iran.
Mirhafez SR; Zarifian A; Movahedi A; Ferns GA; Sathyapalan T; Ghayour-Mobarhan M; Sahebkar A
Arch Med Sci Atheroscler Dis; 2023; 8():e89-e95. PubMed ID: 38089159
[TBL] [Abstract][Full Text] [Related]
13. Current and Emerging Treatment Options for Uterine Fibroids.
Ali M; Ciebiera M; Wlodarczyk M; Alkhrait S; Maajid E; Yang Q; Hsia SM; Al-Hendy A
Drugs; 2023 Dec; 83(18):1649-1675. PubMed ID: 37922098
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic Carbohydrate Restriction as a Metabolic Modality for the Prevention and Treatment of Abnormal Uterine Bleeding.
Salcedo AC; Yun J; Carter C; Hart E
Nutrients; 2023 Aug; 15(17):. PubMed ID: 37686792
[TBL] [Abstract][Full Text] [Related]
15. Increased Occurrence of Cutaneous Leiomyomas and Dermatofibromas in Patients with Uterine Leiomyomas without Fumarate Hydratase Gene Mutations.
Campione E; Di Prete M; Costanza G; Saggini A; Agostinelli S; Terrinoni A; Centofanti F; Rapanotti MC; Bianchi L; Ferlosio A; Scioli MG; Orlandi A
Dermatopathology (Basel); 2023 Aug; 10(3):231-243. PubMed ID: 37606484
[TBL] [Abstract][Full Text] [Related]
16. Targeting fibrotic signaling pathways by EGCG as a therapeutic strategy for uterine fibroids.
Islam MS; Parish M; Brennan JT; Winer BL; Segars JH
Sci Rep; 2023 May; 13(1):8492. PubMed ID: 37231028
[TBL] [Abstract][Full Text] [Related]
17. Progesterone Signaling and Uterine Fibroid Pathogenesis; Molecular Mechanisms and Potential Therapeutics.
Ali M; Ciebiera M; Vafaei S; Alkhrait S; Chen HY; Chiang YF; Huang KC; Feduniw S; Hsia SM; Al-Hendy A
Cells; 2023 Apr; 12(8):. PubMed ID: 37190026
[TBL] [Abstract][Full Text] [Related]
18. Myostatin Overexpression and Smad Pathway in Detrusor Derived from Pediatric Patients with End-Stage Lower Urinary Tract Dysfunction.
Salemi S; Schori LJ; Gerwinn T; Horst M; Eberli D
Int J Mol Sci; 2023 Feb; 24(5):. PubMed ID: 36901894
[TBL] [Abstract][Full Text] [Related]
19. Gene Expression Profile of Uterine Leiomyoma from Women Exposed to Different Air Pollution Levels in Metropolitan Cities of Sao Paulo, Brazil.
Dos Anjos LG; de Almeida BC; Baracat EC; Al-Hendy A; Yang Q; Carvalho KC
Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768749
[TBL] [Abstract][Full Text] [Related]
20. The Effects of Periostin Expression on Fibroid-Like Transition of Myometrial Cells.
Lenis YY; George JW; Lind S; Balboula A; Teixeira JM; Patterson AL
Reprod Sci; 2023 May; 30(5):1616-1624. PubMed ID: 36418534
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
